Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001862720 | SCV002192563 | pathogenic | not provided | 2023-08-07 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Asn654Lysfs*5) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is present in population databases (rs749103801, gnomAD 0.006%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 812318). This variant is also known as c.1961_1962insA. This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa (PMID: 29550188). |
Fulgent Genetics, |
RCV002497324 | SCV002810701 | likely pathogenic | Retinitis pigmentosa 25 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV002497324 | SCV004195244 | pathogenic | Retinitis pigmentosa 25 | 2024-03-11 | criteria provided, single submitter | clinical testing | |
Sharon lab, |
RCV001003025 | SCV001161081 | pathogenic | Retinitis pigmentosa | 2019-06-23 | no assertion criteria provided | research |